ConductScience.org, home

Paper9356100

Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease.

Sakamoto T and 5 others. Anesth Analg, 1997. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Papers, record 9356100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9356100

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease.
PubMed
Journal
Anesth Analg
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
3.04
iCite
Revised in PubMed
2019-07-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakamoto TT
2Kawaguchi MM
3Kurehara KK
4Kitaguchi KK
5Furuya HH
6Karasawa JJ

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrainMajor topic
Ischemic Attack, TransientMajor topic
Moyamoya DiseaseMajor topic
Postoperative ComplicationsMajor topic
Adolescent
Adult
Anesthesia, General
Cerebrovascular Circulation
Child
Child, Preschool
Female
Humans
Infant
Intraoperative Complications
Male
Middle Aged
Retrospective Studies
Risk Factors
Surgical Procedures, Operative
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
42894060Comparison of outcomes after direct extracranial-to-intracranial bypass for moyamoya disease and non-moyamoya pathology: A systematic review and meta-analysis.Neurosurg Rev2026https://conductscience.org/library/papers/42894060PubMed
42824889Enhanced Recovery After Surgery Consensus Protocol for Cerebral Bypass in Moyamoya Disease.Neurosurg Pract2026https://conductscience.org/library/papers/42824889PubMed
42452416Anesthetic Management for Encephaloduroarteriosynangiosis in Moyamoya Disease: A Hemodynamic and Neuromonitoring-Integrated Framework.J Clin Med2026https://conductscience.org/library/papers/42452416PubMed
40632257Cerebral Ischemic Complications of Surgical Treatment in Patients with Moyamoya Disease.Acta Neurochir Suppl2025https://conductscience.org/library/papers/40632257PubMed
38244093Complications associated with combined direct and indirect bypass in Moyamoya Disease: A meta-analysis.Neurosurg Rev2024https://conductscience.org/library/papers/38244093PubMed
37013602Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease.Chin Neurosurg J2023https://conductscience.org/library/papers/37013602PubMed
36153860Pseudoaneurysm formation or dural arteriovenous fistula formation at the middle meningeal artery following revascularization surgery in Moyamoya disease.J Cerebrovasc Endovasc Neurosurg2023https://conductscience.org/library/papers/36153860PubMed
36130575Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative case.J Neurosurg Case Lessons2022https://conductscience.org/library/papers/36130575PubMed
35909708A single - center retrospective observational study on patients undergoing Encephalo-Duro-Arterio -Myo-Synangiosis in patients with moyamoya disease.Brain Circ2022https://conductscience.org/library/papers/35909708PubMed
35050820Endovascular treatment of main trunk aneurysms in the residual anterior circulation in moyamoya disease.Neuroradiol J2022https://conductscience.org/library/papers/35050820PubMed
32166202Complications following Encephalo-Duro-Arterio-Myo-Synangiosis in a case of Moyamoya disease.Brain Circ2020https://conductscience.org/library/papers/32166202PubMed
31092214Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis.BMC Neurol2019https://conductscience.org/library/papers/31092214PubMed
26867219Voxel Based Analysis of Surgical Revascularization for Moyamoya Disease: Pre- and Postoperative SPECT Studies.PLoS One2016https://conductscience.org/library/papers/26867219PubMed
26180613Cognitive Outcome of Pediatric Moyamoya Disease.J Korean Neurosurg Soc2015https://conductscience.org/library/papers/26180613PubMed
25883498Retrospective analysis of perioperative factors on outcome of patients undergoing surgery for Moyamoya disease.J Neurosci Rural Pract2015https://conductscience.org/library/papers/25883498PubMed
24403389Moyamoya disease, revascularisation surgery and anaesthetic considerations.BMJ Case Rep2014https://conductscience.org/library/papers/24403389PubMed
22323934Ischemic complications occurring in the contralateral hemisphere after surgical treatment of adults with moyamoya disease.J Korean Neurosurg Soc2011https://conductscience.org/library/papers/22323934PubMed
22102960Unpredictable postoperative global cerebral infarction in the patient of williams syndrome accompanying moyamoya disease.J Korean Neurosurg Soc2011https://conductscience.org/library/papers/22102960PubMed
17486352Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.Childs Nerv Syst2007https://conductscience.org/library/papers/17486352PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9356100

GET https://conductscience.org/api/papers/v1/9356100/authors